The first study, published in the journal Nature6, found that
young mice treated with low doses of common antibiotics gained 10 - 15 percent more fat than the untreated controls.
As expected,
young mice treated with THC performed slightly worse on behavioral tests of memory and learning.
Not exact matches
After 18 - month - old
mice were
treated with NMN for two months, their capillary density was restored to levels typically seen in
young mice, and they experienced a 56 to 80 percent improvement in endurance.
Researchers found that FTIs not only prevented cardiovascular damage in
young mice, but also reversed the disease in older animals
treated after the onset of arterial damage.
The researchers also
treated old
mice with 8 injections of blood plasma taken from either
young mice or other geezers.
Bottom Line:
Young mice that received molecularly targeted therapies used to
treat brain cancer in human patients sustained cognitive and behavioral deficits, but the deficits were largely reversible through environmental stimulation and physical exercise.
The
mice used in all these the studies were
treated with memantine from a very
young age, and we don't know what would happen if the
mice received it only after they got sick - which is how most human patients are
treated.
Treating mice with anti-STAT5 drugs for a few weeks after they finished nursing their
young lessened the elevated cancer risk, and so the next challenge is to see if this approach will also be effective in human clinical trials.
We also measured cross-sectional muscle fiber areas in quadriceps femoris muscle of rapamycin - or vehicle -
treated aged
mice and corresponding
young controls (16 - and 25 - month cohorts; Figure 4, G and H), which showed the expected aging - associated decrease in cross-sectional muscle fiber area.
To examine cardiac aging phenotypes, we performed echocardiography in rapamycin - and vehicle -
treated aged
mice and
young controls.
Researchers reporting in the July 31 issue of Cell discovered that
young adult
mice that exercised and took a drug originally developed to
treat metabolic diseases ran considerably farther compared with
mice who only exercised.